SYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy and well-characterized safety, building on Biogen’s…
KEYPOINTS: GlaxoSmithKline (NYSE:GSK) announces that the European Commission has approved Nucala (Mepolizumab), a monoclonal antibody that targets interleukin-5, for use in three…
KEYPOINTS: AbbVie announces that the European Commission (EC) has approved SKYRIZI (Risankizumab, 150 mg, subcutaneous injection at week 0, week 4, and…
KEYPOINTS: Biocon Biologics and Viatris Inc have launched Semglee (insulin glargine-yfgn) injection, a branded product, and Insulin Glargine (insulin glargine-yfgn) injection, an…
Two monoclonal antibody medicines for treating COVID-19 have been recommended for authorisation by the European Medicines Agency on Thursday (11 November), sparking…
KEYWORDS: Bioglan, the Swedish subsidiary of the Spanish pharmaceutical company, and STADA Arzneimittel AG have signed an agreement to expand the production…
SUMMARY: PharmaEssentia Corporation a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in…
KEYPOINTS: In this programme, DawaaDost will retail Metformin 1000 mg tablets from the top 10 pharmaceutical companies in the country. One in…
Pune-based Serum Institute of India (SII) is expected to supply 25 million doses to the Covax facility till December, as it looks…
KEYPOINTS: Pfizer announced that its oral antiviral cut the risk of hospitalization or death by 89% in an interim analysis of the…